Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of latently infected cells. The 'shock and kill' approach to a cure proposes to eliminate this reservoir via transcriptional activation of latent proviruses, enabling direct or indirect killing of infected cells. Currently available latency-reversing agents (LRAs) have however proven ineffective. To understand why, we used a novel HIV reporter strain in primary CD4+ T cells and determined which latently infected cells are reactivatable by current candidate LRAs. Remarkably, none of these agents reactivated more than 5% of cells carrying a latent provirus. Sequencing analysis of reactivatable vs. non-reactivatable populations revealed that the integra...
SummaryHighly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot eliminat...
The so-called shock and kill therapies aim to combine HIV-1 reactivation by latency-reversing agents...
The development of suitable experimental systems for studying HIV latency in primary cells that perm...
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of laten...
Upon infection of its host cell, human immunodeficiency virus (HIV) establishes a quiescent and non-...
Human immunodeficiency virus type 1 (HIV-1) infection is a chronic condition, where viral DNA integr...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is the "shock ...
HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim at incr...
The presence of T cell reservoirs in which human immunodeficiency virus (HIV) establishes latency by...
<div><p>HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim...
HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim at incr...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
The "shock-and-kill" strategy is one of the most explored HIV-1 cure approaches to eliminate latent ...
Combinatory antiretroviral therapy (cART) reduces human immunodeficiency virus type 1 (HIV-1) replic...
SummaryHighly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot eliminat...
The so-called shock and kill therapies aim to combine HIV-1 reactivation by latency-reversing agents...
The development of suitable experimental systems for studying HIV latency in primary cells that perm...
Human immunodeficiency virus (HIV) infection is currently incurable, due to the persistence of laten...
Upon infection of its host cell, human immunodeficiency virus (HIV) establishes a quiescent and non-...
Human immunodeficiency virus type 1 (HIV-1) infection is a chronic condition, where viral DNA integr...
Transcriptional silencing of HIV in CD4 T cells generates a reservoir of latently infected cells tha...
One of the most explored therapeutic approaches aimed at eradicating HIV-1 reservoirs is the "shock ...
HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim at incr...
The presence of T cell reservoirs in which human immunodeficiency virus (HIV) establishes latency by...
<div><p>HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim...
HIV latency is a major obstacle to curing infection. Current strategies to eradicate HIV aim at incr...
Aids has become the leading cause of death world-wide. Much research has been done on the causal age...
The "shock-and-kill" strategy is one of the most explored HIV-1 cure approaches to eliminate latent ...
Combinatory antiretroviral therapy (cART) reduces human immunodeficiency virus type 1 (HIV-1) replic...
SummaryHighly active antiretroviral therapy (HAART) suppresses HIV-1 replication but cannot eliminat...
The so-called shock and kill therapies aim to combine HIV-1 reactivation by latency-reversing agents...
The development of suitable experimental systems for studying HIV latency in primary cells that perm...